GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BibbInstruments AB (XSAT:BIBB) » Definitions » Float Percentage Of Total Shares Outstanding

BibbInstruments AB (XSAT:BIBB) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 17, 2025)


View and export this data going back to 2017. Start your Free Trial

What is BibbInstruments AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BibbInstruments AB's float shares is 0.00 Mil. BibbInstruments AB's total shares outstanding is 40.22 Mil. BibbInstruments AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BibbInstruments AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BibbInstruments AB's Institutional Ownership is 8.15%.


BibbInstruments AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BibbInstruments AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/40.22
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BibbInstruments AB Business Description

Industry
Traded in Other Exchanges
Address
Scheelevagen 2, Medicon Village, Lund, SWE, SE-223 81
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.

BibbInstruments AB Headlines

No Headlines